Goelzer Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,701
Closed -$285K 267
2019
Q2
$285K Sell
1,701
-25,173
-94% -$3.49M 0.03% 230
2019
Q1
$3.94M Sell
26,874
-1,179
-4% -$171K 0.37% 89
2018
Q4
$3.75M Sell
28,053
-4,296
-13% -$704K 0.48% 86
2018
Q3
$6.16M Buy
32,349
+6,794
+27% +$1.25M 0.69% 51
2018
Q2
$4.26M Buy
25,555
+29
+0.1% +$4.66K 0.5% 84
2018
Q1
$4.3M Buy
25,526
+4,507
+21% +$756K 0.51% 85
2017
Q4
$3.44M Sell
21,019
-15,919
-43% -$2.86M 0.39% 100
2017
Q3
$7.57M Sell
36,938
-299
-0.8% -$69.5K 0.89% 28
2017
Q2
$9.05M Sell
37,237
-173
-0.5% -$40.7K 1.11% 24
2017
Q1
$8.94M Buy
37,410
+4,902
+15% +$1.14M 1.11% 22
2016
Q4
$6.83M Buy
32,508
+1,340
+4% +$278K 0.89% 29
2016
Q3
$7.18M Buy
31,168
+197
+0.6% +$48.1K 0.97% 24
2016
Q2
$7.16M Buy
30,971
+12,087
+64% +$2.79M 0.99% 25
2016
Q1
$5.06M Sell
18,884
-281
-1% -$80.4K 0.72% 44
2015
Q4
$5.99M Buy
19,165
+2,752
+17% +$819K 0.87% 29
2015
Q3
$4.46M Buy
16,413
+86
+0.5% +$26.4K 0.71% 50
2015
Q2
$4.96M Sell
16,327
-335
-2% -$99.9K 0.75% 41
2015
Q1
$4.96M Buy
+16,662
New +$4.75M 0.75% 44

Other funds holding AGN

Goelzer Investment Management's AGN Position: Q3 2019 in Review

Goelzer Investment Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,701 shares — an estimated $285K sold.

Goelzer Investment Management first reported a position in AGN in Q1 2015 and held it in 18 quarters. The position peaked at $9.05M in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Goelzer Investment Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Goelzer Investment Management sold 1,701 Allergan plc shares in Q3 2019, an estimated $285K.
  • Goelzer Investment Management first reported a position in Allergan plc in Q1 2015 and held it in 18 quarters.
  • Goelzer Investment Management's Allergan plc position peaked at $9.05M in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Goelzer Investment Management's 13F filing for Q3 2019, filed 6 Nov 2019.